Delivery Order SPE2DB20D2014-SPE2DB25FA95S
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,161.81 firm fixed-price delivery order is for the XHANCE 93 MCG NASAL SPRAY 16ML product, with a completion date of December 18, 2024. The contract award is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The award, valued at $4,467.65, is a Delivery Order contract for the supply of XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a completion date of June 25, 2024 and is a Firm Fixed Price contract. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization registered in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,086.89 firm-fixed-price delivery order is for the supply of XHANCE 93 MCG Nasal Spray 16ML, with a period of performance through August 23, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,436.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XHANCE 93 MCG Nasal Spray, a pharmaceutical product, with a completion date of December 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XHANCE 93 MCG NASAL SPRAY 16ML. The $4,281.82 firm fixed-price delivery order has a completion date of December 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,126.58 firm fixed-price delivery order is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of XHANCE 93 MCG nasal spray 16ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract has a firm fixed price pricing type and a potential value of $3,963.75. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,147.64 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of XHANCE 93 MCG Nasal Spray, a pharmaceutical product, with an ultimate completion date of October 20, 2022. The award was made on October 19, 2022 with a Firm Fixed Price pricing type. This contract is not designated as a set-aside....
This federal contract award is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,018.98 and is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is December 18, 2024. This contract is not designated with a set-aside requirement,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XHANCE 93 MCG nasal spray. The firm-fixed-price contract, valued at $7,435.60, has a period of performance through February 14, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...